PIII

NASDAQ

P3 Health Partners Inc.

SectorHealth CareIndustryMedical/Nursing ServicesIPO2021

News25/Ratings5

P3 Health Partners Inc. provides primary health care services. The company offers clinical operations and population health management services, as well as provides senior wellness centers. The company is based in Henderson, Nevada.

News · 26 weeks19-40%

2025-10-262026-04-19

Mix990d

SEC Filings6(67%)
Earnings3(33%)

Latest news

25 items

3dSEC
SEC Form PRE 14A filed by P3 Health Partners Inc.
PRE 14A - P3 Health Partners Inc. (0001832511) (Filer)
7dPR
P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2026 on Thursday, May 14, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter 2026 Earnings Conference Call Date & Time May 14, 2026, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 International 1-412-317-0692 Ask to be joined into the P3 Health Partners call
20dSEC
SEC Form S-8 filed by P3 Health Partners Inc.
S-8 - P3 Health Partners Inc. (0001832511) (Filer)
28dSEC
SEC Form 10-K filed by P3 Health Partners Inc.
10-K - P3 Health Partners Inc. (0001832511) (Filer)
28dSEC
P3 Health Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - P3 Health Partners Inc. (0001832511) (Filer)
28dPR
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
Providing 2026 Guidance, Indicating a $10 Million Adjusted EBITDA Midpoint Management to Host Conference Call and Webcast March 26, 2026 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2025, and provided 2026 guidance. "2025 was a year of meaningful progress in repositioning the business. We strengthened our contract economics, improved provider alignment, and built a more disciplined operating foundation. With that work in place, we enter 2026 with a clear path to profitability and approxi
29dSEC
P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - P3 Health Partners Inc. (0001832511) (Filer)
41dPR
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for fourth quarter and full year 2025 on Thursday, March 26, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter and Full Year 2025 Earnings Conference Call Date & Time March 26, 2026, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 International 1-412-317-0692 Ask to be joined into t
65dSEC
P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - P3 Health Partners Inc. (0001832511) (Filer)
90dINSIDER
Amendment: Director Wasson Gregory D was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)
4/A - P3 Health Partners Inc. (0001832511) (Issuer)
90dINSIDER
Amendment: Director Tolan Mary A was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)
4/A - P3 Health Partners Inc. (0001832511) (Issuer)
90dINSIDER
Amendment: Director Leisure Lawrence B. was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)
4/A - P3 Health Partners Inc. (0001832511) (Issuer)
90dINSIDER
Amendment: Director Kazarian Gregory N. was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)
4/A - P3 Health Partners Inc. (0001832511) (Issuer)
90dINSIDER
Amendment: Director Thierer Mark was granted 4,000 units of Class A Common Stock, increasing direct ownership by 46% to 12,662 units (SEC Form 4)
4/A - P3 Health Partners Inc. (0001832511) (Issuer)
90dINSIDER
Amendment: Director Price Thomas Edmunds was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)
4/A - P3 Health Partners Inc. (0001832511) (Issuer)
90dINSIDER
Amendment: Director Park Jeffrey G was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)
4/A - P3 Health Partners Inc. (0001832511) (Issuer)
142dPR
P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO
New Partnership Strengthens Value-Based Care Platform for Primary Care Providers P3 Health Partners ("P3") (NASDAQ:PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Organization (MSO) for its ACO lines of business designed to expand value-based care and enhance support for primary care physicians across Arizona, California, Nevada, Oregon, and North Carolina. This partnership brings together two highly aligned organizations with a shared belief in the power of primary care, including independent physicians, and a proven record of success in value-based models. The joint venture also expands P3's footprint into Ma
146dSEC
P3 Health Partners Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
8-K - P3 Health Partners Inc. (0001832511) (Filer)
161dPR
P3 Health Partners Announces Third Quarter 2025 Results
P3 Reports Continued Operational Progress and Expansion of Care Enablement Model in a Transitional Year $120 to $170 Million EBITDA Expansion Opportunity Strengthens Path to Meaningful Profitability Management to Host Conference Call and Webcast November 14, 2025 at 8:00 AM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2025. "Our core business continues to demonstrate positive momentum in the third quarter, driven by the expansion of our Care Enablement Model," said Aric Coffman, CEO of P3. "Medical cost trends
184dPR
P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2025 and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 5:00am PT/ 8:00am ET the same day. Title & Webcast P3 Health Third Quarter 2025 Earnings Conference Call Date & Time November 14, 2025, 8:00am Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 A
218dPR
P3 Health Partners to Participate in the Jefferies Healthcare Services Conference
P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Jefferies Healthcare Services Conference. Management will participate in a fireside chat on Tuesday, September 30, 2025, at 2:25 PM Central Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3's investor relations webpage for 30 days following the presentation. About P3 Health Partners (NASDAQ:PIII): P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by impro
237dSEC
P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - P3 Health Partners Inc. (0001832511) (Filer)
238dANALYST
Lake Street resumed coverage on P3 Health Partners with a new price target
Lake Street resumed coverage of P3 Health Partners with a rating of Buy and set a new price target of $20.00
241dPR
Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States
GREENWOOD VILLAGE, Colo., Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which officially launched in May 2025. P3 Health Partners is a population health management organization that supports providers with administrative services and care coordination for Medicare members. This milestone marks a significant achievement in Catalyst's work to help P3 deliver high-quality, efficient service to members across a multi-state footprint. P3 operates in Arizona, Oregon, N
252dSEC
SEC Form 10-Q filed by P3 Health Partners Inc.
10-Q - P3 Health Partners Inc. (0001832511) (Filer)